Celebrex and Bextra Class Action Settlement Paid

THIS IS A MARCH 13 2015 UPDATE FOLLOWING ONTARIO AND QUEBEC COURT APPROVAL IN FEBRUARY OF THE ACTUAL PAYOUT OF APPROVED CLAIMS IN THE CELEBREX BEXTRA CLASS ACTION. THE CLAIMS HAVE BEEN PAID. NO NEW CLAIMS CAN BE MADE: Celebrex, Vioxx and Bextra were similar class popular anti inflammatory prescription drugs until late in 2004.
Read More >>

Liver Damage is Caused by Excessive Tylenol Use

In the United States claims against the manufacturer of Tylenol and other acetaminophen manufacturers are proceeding through Multi District Litigation co-ordinated by the Eastern District Court in Pennsylvania.  Tylenol is the most popular analgesic (pain killer) on the market. Serious damage claims related to liver damage and liver failure are proceeding in the USA, but
Read More >>

Murray Miskin and Personal Injury Law

In the Durham Region and Peterborough and the Kawarthas in Ontario there are a few currently practicing local lawyers who are knowledgeable and experienced in personal injury law.  One of them is Murray Miskin who lives and works full time in Peterborough County.  The Miskin Law Office was based primarily in Whitby from 1985 to
Read More >>

STATUS OF CLASS ACTION SETTLEMENT FOR VIOXX

  THE VIOXX CLASS ACTION SETTLEMENT FOR CANADA IS BEING IMPLEMENTED. FILING CLAIMS OPENED APRIL 20, 2013 AND CLOSED AUGUST 19, 2013. CLAIMS ARE STILL BEING ASSESSED BY THE CLAIMS ADMINISTRATOR AS OF APRIL 2015.  THIS POST DETAILS HOW THE SETTLEMENT PROCESS PROCEEDED.  FOR UP TO DATE INFORMATION ON THE STATUS OF CLAIM NOW PLEASE
Read More >>

Celebrex Class Action Lawsuit Settlement Compared

    PLEASE BE AWARE THAT THE DEADLINE FOR SUBMITTING CELEBREX OR BEXTRA CLAIMS PASSED ON DECEMBER 20, 2012 Pfizer’s Cox 2 inhibitor drug Celebrex is similar to Merck’s Vioxx and Pfizer’s more powerful version Bextra.  Celebrex remains on the market and Bextra was banned soon after Vioxx in 2004.  While Merck’s equivalent drug Vioxx
Read More >>

  • Miskin Law Posts

    • GET YOUR FREE CASE EVALUATION